CIK: 1185858 - Address: C/O Regulus Therapeutics Inc., 4224 Campus Point Court #210, San Diego, CA 92121
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1170-1111132
S%wins71864343575058

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/2/17 19:21
5/31/17
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS-570153.930-4-1131D
5/3/16 19:12
4/29/16
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS-521157.2133-3-932D4710580-3-1-1-1212-6
3/3/15 20:55
3/2/15
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS-579158.7633-4-1031D813116-317210-210-1-4
8/30/13 17:36
8/28/13
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS-502109.6633-5-1527D10931199003-422351530
3/1/13 17:31
2/28/13
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS.d-8292.9433-1-331D81389698920011141937
12/12/12 18:40
12/10/12
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS.d-60589.0033-7-1831D73573473412-1-1-431028
12/8/08 19:15
12/5/08
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS-1,20557.3733-21-5021D-17430-40-145000-17-13-3
11/21/05 12:57
11/18/05
AMGNAmgen IncDEHealthBioPrdBiological Products, (No DiagBaltimore DavidCADS.d-2,48982.9733-30-817D3839345910421-2-6-10-20-12

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact